ZOGENIX, INC. (23) | License Agreements (2)
- Amendment No. 1 to Exclusive License Agreement by and between the Trustees of Columbia University and Modis Therapeutics, Inc., dated December 5, 2019 (Filed With SEC on March 2, 2020)
- Exclusive License Agreement by and between the Trustees of Columbia University and Modis Therapeutics, Inc. (as successor-in-interest to Meves Pharmaceuticals, LLC), dated... (Filed With SEC on November 7, 2019)
